Radiology · Nov 1, 2026
Temporal Trends in High-Risk Benign Breast Disease Detection at Screening Mammography: Results from the Breast Cancer Surveillance Consortium
By Sprague BL, Ponzini M, Sattayapiwat O et al.
Background Nationally representative data comparing high-risk benign breast disease (BBD) detection with digital breast tomosynthesis (DBT) versus digital mammography are lacking. Purpose To describe temporal trends in high-risk BBD detection rates at screening mammography in the Breast Cancer Surveillance Consortium (BCSC) over nearly 2 decades and to evaluate the association between mammographic modality and high-risk BBD detection. Materials and Methods In this retrospective cohort study using prospectively collected data from the BCSC, screening mammograms obtained from 2005 to 2022 among women aged 40 to 79 years at 97 health care facilities were analyzed; examinations in women with prior breast cancer or mastectomy were excluded. Regression analyses were used to estimate annual percent change (APC) in detection rates, and multivariable logistic regression was used to estimate adjusted odds ratios (ORs) according to mammographic modality. Results A total of 4 469 664 screening mammograms in 1 190 380 women (mean age, 57.3 years ± 10.1 [SD]) were included. The overall high-risk BBD detection rate was 1.11 per 1000 examinations, with no evidence of a temporal trend since 2017 (APC = 5.3% [95% CI: -1.1, 21.9]; P = .09). Atypical ductal hyperplasia detection declined from 2009 to 2017 (APC = -7.4% [95% CI: -12.0, -5.4]; P < .001). Detection of radial sclerosing lesions (APC = 5.4% [95% CI: 3.5, 7.8]; P < .001) and atypical papillary lesions (APC = 19.0% [95% CI: 14.8, 25.1]; P < .001) increased from 2005 to 2022. Compared with digital mammography, DBT was associated with increased detection of high-risk BBD overall (OR = 1.36 [95% CI: 1.24, 1.49]; P < .001), lobular carcinoma in situ (OR = 1.37 [95% CI: 1.02, 1.85]; P = .04), atypical lobular hyperplasia (OR = 1.45 [95% CI: 1.19, 1.77]; P < .001), and radial sclerosing lesions (OR = 2.64 [95% CI: 2.15, 3.23]; P < .001). Conclusion Over the past 2 decades, detection of atypical papillary lesions and radial sclerosing lesions increased, whereas detection of atypical ductal hyperplasia declined. DBT was associated with increased detection of high-risk BBD, including lobular carcinoma in situ, atypical lobular hyperplasia, and radial sclerosing lesions. © RSNA, 2026 Supplemental material is available for this article. See also the editorial by Hooley in this issue.